ATE186728T1 - Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung - Google Patents

Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung

Info

Publication number
ATE186728T1
ATE186728T1 AT90110191T AT90110191T ATE186728T1 AT E186728 T1 ATE186728 T1 AT E186728T1 AT 90110191 T AT90110191 T AT 90110191T AT 90110191 T AT90110191 T AT 90110191T AT E186728 T1 ATE186728 T1 AT E186728T1
Authority
AT
Austria
Prior art keywords
imidazochinoxalinones
azanalogues
production
venodilatory
inodilatory
Prior art date
Application number
AT90110191T
Other languages
English (en)
Inventor
David Daniel Davey
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Application granted granted Critical
Publication of ATE186728T1 publication Critical patent/ATE186728T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90110191T 1989-05-31 1990-05-29 Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung ATE186728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/359,182 US5055465A (en) 1989-05-31 1989-05-31 Imidazoquinoxalinones, their aza analogs and process for their preparation

Publications (1)

Publication Number Publication Date
ATE186728T1 true ATE186728T1 (de) 1999-12-15

Family

ID=23412679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90110191T ATE186728T1 (de) 1989-05-31 1990-05-29 Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung

Country Status (7)

Country Link
US (1) US5055465A (de)
EP (1) EP0400583B1 (de)
AT (1) ATE186728T1 (de)
DE (1) DE69033355T2 (de)
DK (1) DK0400583T3 (de)
ES (1) ES2138956T3 (de)
GR (1) GR3032611T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854419A (en) * 1989-11-17 1998-12-29 Schering Aktiengesellschaft Tricyclic pteridinones and a process for their preparation
US5602252A (en) * 1989-11-17 1997-02-11 Berlex Laboratories, Inc. Tricyclic pteridinones and a process for their preparation
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE69334237D1 (de) * 1992-06-22 2008-09-25 State Of Oregon Through Oregon Glycinrezeptorantagonisten und ihre verwendung
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
US5306819A (en) * 1992-08-27 1994-04-26 Neurogen Corporation Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
DE4310523A1 (de) * 1993-03-31 1994-10-06 Basf Ag Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
JPH09510695A (ja) * 1994-01-03 1997-10-28 エイシア・ファーマシュウティカルズ，インコーポレイテッド ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用
ATE214069T1 (de) * 1994-02-11 2002-03-15 Novo Nordisk As Heterocyclische verbindungen und ihre herstellung und verwendung
BR9509055A (pt) * 1994-09-30 1998-06-23 Basf Ag Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
DE19510965A1 (de) * 1995-03-24 1996-09-26 Asta Medica Ag Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
DE19611476A1 (de) * 1996-03-22 1997-09-25 Basf Ag Neue heterocyclische substituierte Imidazolo-chinoxalinone, ihre Herstellung und Verwendung
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
EE200100377A (et) * 1999-01-20 2002-10-15 Arzneimittelwerk Dresden Gmbh Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
WO2000056719A1 (en) * 1999-03-22 2000-09-28 Bristol-Myers Squibb Company FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE
US6465465B1 (en) * 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
EP1312363A1 (de) * 2001-09-28 2003-05-21 Pfizer Products Inc. Behandlungsverfahren und kits bestehend aus Wachstumshormonsekretionsförderern
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
KR101563103B1 (ko) * 2006-12-13 2015-10-23 아스카 세이야쿠 가부시키가이샤 퀴녹살린 유도체
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
CN101918408A (zh) * 2007-11-30 2010-12-15 惠氏有限责任公司 作为磷酸二酯酶10的抑制剂的芳基和杂芳基稠合的咪唑并[1,5-a]吡嗪
AU2008329072A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10
WO2010085570A1 (en) 2009-01-23 2010-07-29 Takeda Pharmaceutical Company Limited Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
WO2011014681A1 (en) 2009-07-30 2011-02-03 Takeda Pharmaceutical Company Limited Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
US20110190192A1 (en) * 2009-12-15 2011-08-04 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
ES2747423T3 (es) 2010-09-07 2020-03-10 Astellas Pharma Inc Compuesto de quinoxalina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138564A (en) * 1977-08-03 1979-02-06 American Home Products Corporation Tetrahydro[1H]pyrazino[1,2-a]azaquinoxalin-5(6H)-ones and derivatives thereof
SE441449B (sv) * 1979-02-09 1985-10-07 Roussel Uclaf Heterocykliska derivat och farmaceutiska kompositioner innehallande dessa derivat
US4333394A (en) * 1979-12-31 1982-06-08 Brown Stanford M Method for handling and baling metallic scrap material
US4440929A (en) * 1981-07-16 1984-04-03 Usv Pharmaceutical Corporation Imidazoquinoxaline compounds
US4761414A (en) * 1986-08-19 1988-08-02 G. D. Searle & Co. Substituted 1H-pyrimido[1,2-a-]-pyrido[3,4-e]pyrazine 6 oxides

Also Published As

Publication number Publication date
ES2138956T3 (es) 2000-02-01
US5055465A (en) 1991-10-08
DE69033355D1 (de) 1999-12-23
DK0400583T3 (da) 2000-03-13
GR3032611T3 (en) 2000-05-31
EP0400583B1 (de) 1999-11-17
EP0400583A1 (de) 1990-12-05
DE69033355T2 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
ATE186728T1 (de) Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung
GR853065B (de)
DE68913215D1 (de) Verfahren zur Herstellung hydraulischer Dämpfungsspalten.
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
DE68916130D1 (de) Verfahren zur Herstellung von Block-copolyamid.
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
DE59001820D1 (de) Verfahren zur herstellung von indolcarbonsaeurederivaten.
DE3578687D1 (de) N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung.
DE58907777D1 (de) Verfahren zur Herstellung von Caprolactam.
ATE38832T1 (de) Verfahren zur herstellung von pyrrolidonderivaten.
DE3889046T2 (de) Copolyamide, enthaltend spiro(bis)indane und verfahren zu ihrer herstellung.
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE3870065D1 (de) Zusammensetzungen von polyarylalkanoligomeren, verfahren zu deren herstellung.
DE3781879T2 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69015814T2 (de) Verfahren zur Herstellung von Calciumhypochlorit.
DE69008382T2 (de) Verfahren zur Herstellung von Organosiliziumverbindungen.
DE3888307T2 (de) Verfahren zur Herstellung von Ascorbinsäure-2-phosphat.
ATE100437T1 (de) Bronchospasmolytische verbindungen und verfahren zu ihrer herstellung.
DE3773240D1 (de) Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE3781095D1 (de) Calciumhypochloritzusammensetzungen und verfahren zu ihrer herstellung.
DE69016380D1 (de) Verfahren zur Herstellung von molluskiziden 2,4,5-Tribrompyrrol-3-Carbonitrilen.
ATA102287A (de) Verfahren zur herstellung von neuen 8- bzw. 1,8- substituierten ergolenderivaten
ATE23340T1 (de) 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee